Comparison Between Intravesical Chemotherapy Epirubicin and Mitomycin-C after TURB vs TURB Alone With Recurrence Rate of Non-Muscle Invasive Bladder Cancer: Meta-Analysis

BACKGROUND: Bladder cancer is still a burden on the world of oncology medicine, which every year affects about 3.4 million people globally with 430,000 new cases per year. It is the fourth most common cancer in men and eighth most common women malignancy in the world. This makes bladder cancer a “si...

Descripción completa

Detalles Bibliográficos
Autores principales: Daryanto, Besut, Purnomo, Athaya Febriantyo, Seputra, Kurnia Penta, Budaya, Taufiq Nur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Medical Sciences of Bosnia and Herzegovina 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478828/
https://www.ncbi.nlm.nih.gov/pubmed/36200115
http://dx.doi.org/10.5455/medarh.2022.76.198-201

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478828/
https://www.ncbi.nlm.nih.gov/pubmed/36200115
http://dx.doi.org/10.5455/medarh.2022.76.198-201

Ejemplares similares